Health ❯ Healthcare ❯ Patient Safety

Adverse Effects

Liver Injury Medication Interactions Reporting Mechanisms Drug Side Effects Pancreatitis Treatment-Emergent Adverse Effects Clinical Outcomes Treatment-Related Adverse Effects Drug Tolerability Drug Toxicity Blood Testing Monitoring Vaccine Reactions Monitoring and Reporting Vaccine Safety Vision Loss Vaccine Side Effects Serious Side Effects Hyperkalaemia Major Bleeding Medication Effectiveness Medication Management Ocular Toxicities Medication Guidelines Drug Recalls Clinical Trial Safety Toxicity of Medications Drug Efficacy Withdrawal Symptoms Botulism Symptoms Antibody Development Pancreatitis Risks Cognitive Impairment Monitoring Symptoms Probiotic Use Vaccine Efficacy Thrombosis Respiratory Depression Temporary Health Consequences Genetic Variants Hyperkalemia Monitoring Emergency Room Visits

Lilly Warns of B12-Linked Impurity in Compounded Tirzepatide, Urges FDA Recall

The findings intensify a legal and safety clash over copycat GLP-1 products and untested additives.

JAMA Study Finds 1 in 4 Medicare Patients With Dementia Receive Risky CNS-Active Drugs

FDA Adds Boxed Warning to Elevidys, Narrows Use to Ambulatory Patients 4 and Older

FDA Issues Warning Letters to 18 Websites Selling Unapproved Botox-Like Injectables

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Pharmacogenetic Screening Halves Severe Chemotherapy Reactions in Gastrointestinal Cancer Patients

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure